Clinical Trials Logo

End Stage Cancer clinical trials

View clinical trials related to End Stage Cancer.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06072612 Recruiting - Breast Cancer Clinical Trials

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

BRIA-ABC
Start date: December 5, 2023
Phase: Phase 3
Study type: Interventional

This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor [Retifanlimab], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.

NCT ID: NCT05054907 Recruiting - End Stage Cancer Clinical Trials

Using Wearable Device to Improve Quality of Palliative Care

Start date: September 23, 2021
Phase:
Study type: Observational

This study is going to use wearable devices and smartphones to collect physical data from terminal patients and build a survival predicting model for terminal patients with machine learning. Investigators hypothesize that continuous physical data monitoring could offer a hint to better predictability in end-of-life care.

NCT ID: NCT04883879 Recruiting - End Stage Cancer Clinical Trials

Artificial Intelligence-based Mortality Prediction Among Cancer Patients in the Hospice Ward

Start date: December 11, 2019
Phase:
Study type: Observational

The purpose of this study is to develop a novel deep-learning-based survival prediction model employing patient activity data recorded by a wearable device.

NCT ID: NCT04016038 Recruiting - End Stage Cancer Clinical Trials

Psychosocial Approach and Sedation Practices

Start date: June 1, 2019
Phase:
Study type: Observational [Patient Registry]

This study aims to explore deeply the representations and emotional impact of MS on caregivers (doctors and nurses) and relatives of cancer patients. It also aims to describe their collaboration modalities, roles and responsibilities during the decision-making process, implementation and "control" of MS. The project is a multi-center psychosocial study (home, hospitals and palliative care unit) that will take the form of a comprehensive qualitative study, both prospective (participant observation) and retrospective (interview), of patients with and without cancer, for which MS has been administered.

NCT ID: NCT03679182 Recruiting - Nausea Clinical Trials

Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care

Start date: September 1, 2018
Phase: Phase 2
Study type: Interventional

Oral olanzapine showed superior antiemetic efficacy to metoclopramide as rescue treatment to control breakthrough emesis induced by chemotherapy. This study aims to evaluate safety and efficacy of olanzapine for nausea and vomiting in advanced cancer patients.

NCT ID: NCT03387436 Recruiting - Neoplasms Clinical Trials

The "Hand-in-Hand Study": Improvement of Quality of Life in Palliative Cancer Patients Through Collaborative Advance Care Planning

COLAP
Start date: December 4, 2017
Phase: N/A
Study type: Interventional

This study evaluates the effect of a collaborative advance care planning intervention on the quality of life in palliative oncological patients. Research indicates, that talking about wishes for end of life care and death, may improve the quality of life, but can be difficult for involved parties. The intervention especially developed for this study trys to reduce psychosocial barriers that make conversations about these topics difficult. The study will measure the effect of the intervention on patients and caregivers quality of life. The study will give additional information about implementation of advance care planning interventions in different care settings in a complex health care systems.